or Try an Advanced Search...

    Specialty Drugs Stocks List

    Symbol Grade Name % Change
    INZY D Inozyme Pharma, Inc. -2.75
    BIIB D Biogen Idec Inc. 0.23
    RZLT C Rezolute, Inc. 3.13
    PRTC C PureTech Health plc 0.00
    DCTH C Delcath Systems, Inc. 8.76
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Health Care Plans Medical Care Medical Devices
    Related Stock Lists: Biotechnology Biopharmaceutical Life Sciences Medicine Monoclonal Antibody Alzheimer's Disease Biology Immunology Autoimmune Disorders Biomarker Technology Biomarkers Cancer Treatment Carcinoma Cd20 Central Nervous System Disorders Chemotherapy Chloride Cholangiocarcinoma Choline Chronic Disease

    Related ETFs - A few ETFs which own one or more of the above listed Specialty Drugs stocks.

    Symbol Grade Name Weight
    BIS F ProShares UltraShort Nasdaq Biotechnology 6.12
    PBE C PowerShares Dynamic Biotech & Genome 5.07
    IBRN D iShares Neuroscience and Healthcare ETF 4.68
    BBH B Market Vectors Biotech ETF 4.58
    MNTL C Tema Neuroscience and Mental Health ETF 4.26
    View all Specialty Drugs ETFs...
    Compare ETFs
    Compare BBH to MNTL Compare PBE to BBH Compare PBE to MNTL

        Specialty Drugs Stocks Recent News

        Date Stock Title
        May 17 BIIB Ionis, Biogen Down on Ending Development of ALS Drug
        May 17 BIIB Ionis (IONS), Biogen Down on Ending Development of ALS Drug
        May 16 BIIB Biogen also drops collaboration with Ionis on Angelman syndrome candidate
        May 16 RZLT Rezolute reports Q3 results
        May 16 BIIB Biogen and Ionis drop ALS candidate after trial setback
        May 16 BIIB Biogen, Ionis shelve ALS drug following study failure
        May 16 BIIB REFILE-UPDATE 2-Biogen, Ionis to discontinue development of experimental ALS drug
        May 16 BIIB Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis
        May 16 BIIB Ionis and Biogen Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis
        May 15 RZLT Rezolute Reports Third Quarter Fiscal 2024 Financial Results and Provides Business Update
        May 15 BIIB Eisai projects major growth for Alzheimer's therapy Leqembi
        May 15 BIIB Biogen (BIIB) Partner Begins Filing for Leqembi SC Autoinjector
        May 15 BIIB Biogen Stock Continues Its 20% Sprint On A Twist In Alzheimer's Treatment
        May 15 BIIB Eisai sets new revenue target for Alzheimer’s drug Leqembi
        May 15 BIIB Biogen partner Eisai begins FDA submissions for injectable Alzheimer’s therapy
        May 15 DCTH Delcath Systems Inc (DCTH) Q1 2024 Earnings Call Transcript Highlights: Key Financials and ...
        May 15 BIIB UPDATE 1-Eisai starts rolling submission for injectable version of Alzheimer's drug with US FDA
        May 14 BIIB Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Under the Fast Track Status
        May 14 BIIB Eisai starts rolling submission for injectable version of Alzheimer's drug with US FDA
        May 14 DCTH Delcath Systems Inc (DCTH) Q1 2024 Earnings Call Transcript
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Health Care Plans Medical Care Medical Devices
        Related Stock Lists: Biotechnology Biopharmaceutical Life Sciences Medicine Monoclonal Antibody Cancer Treatment Pharmacy Alzheimer's Disease Autoimmune Disorders Biology Cancer Chemotherapy Clinical Medicine Disease Immune Disorders Immunology Medication Monoclonal Antibodies Oncology S&P 500
        Specialty Drugs

        Specialty drugs are medications that are used to treat complex and chronic conditions, such as cancer, multiple sclerosis, and rheumatoid arthritis. They are typically more expensive than traditional medications and require special handling, storage, and administration. Specialty drugs may also require special monitoring and close follow-up with a healthcare provider.

        Browse All Tags